Filgrastim biosimilar - Blau Farmaceutica
Alternative Names: FILGRASTINE; rHu G CSF - Blau FarmaceuticaLatest Information Update: 26 Apr 2023
At a glance
- Originator Blau Farmaceutica
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor replacements; Granulocyte colony-stimulating factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 29 Mar 2023 Blau Farmaceutica plans a phase III trial for Neutropenia (Adjuvant therapy) in May 2023 (SC) (NCT05790096)